- Home
- WB vs GLUE Comparison
WB vs GLUE Comparison
Compare WB & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WB | GLUE |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WB | GLUE |
|---|---|---|
| Price | $7.68 | $16.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $14.00 | ★ $32.00 |
| AVG Volume (30 Days) | 758.7K | ★ 1.4M |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 7.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $123,672,000.00 |
| Revenue This Year | $8.35 | N/A |
| Revenue Next Year | $1.73 | $2.45 |
| P/E Ratio | ★ $5.66 | $72.42 |
| Revenue Growth | N/A | ★ 63.54 |
| 52 Week Low | $7.09 | $4.30 |
| 52 Week High | $12.96 | $25.77 |
Technical Indicators
Market Signals| Indicator | WB | GLUE |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 33.35 |
| Support Level | $7.09 | $14.52 |
| Resistance Level | $7.78 | $17.40 |
| Average True Range (ATR) | 0.14 | 1.09 |
| MACD | -0.04 | -0.41 |
| Stochastic Oscillator | 9.24 | 13.90 |
Price Performance
Historical ComparisonAbout WB Weibo Corporation
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.
About GLUE Monte Rosa Therapeutics Inc.
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).